Laurion Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Laurion Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-665,400	Closed	-$579K	–	727
2023 Q2	$579K	Hold	665,400	–	–	﹤0.01%	414
2023 Q1	$465K	Hold	665,400	–	–	﹤0.01%	346
2022 Q4	$546K	Hold	665,400	–	–	﹤0.01%	351
2022 Q3	$692K	Hold	665,400	–	–	﹤0.01%	384
2022 Q2	$1.09M	Buy	+665,400	New	+$1.38M	0.02%	271
2018 Q3	–	Sell	-20,000	Closed	-$326K	–	1618
2018 Q2	$326K	Buy	+20,000	New	+$289K	﹤0.01%	1069

Laurion Capital Management's SURF Position: Q3 2023 in Review

Laurion Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 665,400 shares — an estimated $579K sold.

Laurion Capital Management first reported a position in SURF in Q2 2018 and held it in 6 quarters. The position peaked at $1.09M in Q2 2022. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Laurion Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Laurion Capital Management sold 665,400 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $579K.
Laurion Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 6 quarters.
Laurion Capital Management's Surface Oncology, Inc. Common Stock position peaked at $1.09M in Q2 2022.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Laurion Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.